Vertex Pharmaceuticals (VRTX) Capital Expenditures Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.88% |
| Dec 31, 2025 | 64.44% |
| Sep 30, 2025 | 23.38% |
| Jun 30, 2025 | 39.82% |
| Mar 31, 2025 | -13.83% |
| Dec 31, 2024 | 14.43% |
| Sep 30, 2024 | 8.91% |
| Jun 30, 2024 | 11.41% |
| Mar 31, 2024 | -1.19% |
| Dec 31, 2023 | 6.80% |
| Sep 30, 2023 | -38.53% |
| Jun 30, 2023 | 49.42% |
| Mar 31, 2023 | 29.36% |
| Dec 31, 2022 | 26.22% |
| Sep 30, 2022 | 30.67% |
| Jun 30, 2022 | 48.25% |
| Mar 31, 2022 | 52.19% |
| Dec 31, 2021 | 58.07% |
| Sep 30, 2021 | 35.82% |
| Jun 30, 2021 | 19.00% |
| Mar 31, 2021 | 34.29% |
| Dec 31, 2020 | 3.52% |
| Sep 30, 2020 | 84.22% |
| Jun 30, 2020 | 0.92% |
| Mar 31, 2020 | 20.56% |
| Dec 31, 2019 | 4.16% |
| Sep 30, 2019 | 20.50% |
| Jun 30, 2019 | 0.91% |
| Mar 31, 2019 | 14.64% |
| Dec 31, 2018 | 7.69% |
| Sep 30, 2018 | 33.46% |
| Jun 30, 2018 | 30.19% |
| Mar 31, 2018 | 40.49% |
| Dec 31, 2017 | 43.08% |
| Sep 30, 2017 | 44.34% |
| Jun 30, 2017 | 14.09% |
| Mar 31, 2017 | -10.59% |
| Dec 31, 2016 | 0.72% |
| Sep 30, 2016 | -9.15% |
| Jun 30, 2016 | 106.76% |
| Mar 31, 2016 | -10.33% |
| Dec 31, 2015 | -23.56% |
| Sep 30, 2015 | -25.64% |
| Jun 30, 2015 | -4.78% |
| Mar 31, 2015 | 19.71% |
| Dec 31, 2014 | 16.30% |
| Sep 30, 2014 | -2.35% |
| Mar 31, 2014 | 47.38% |
| Dec 31, 2013 | 0.10% |
| Sep 30, 2013 | 19.57% |
| Jun 30, 2013 | -42.92% |
| Mar 31, 2013 | 74.79% |
| Dec 31, 2012 | 54.68% |
| Sep 30, 2012 | 65.12% |
| Jun 30, 2012 | 50.21% |
| Mar 31, 2012 | -2.20% |